| [1] |
ZHANG Huimin, ZHAN Shuqin.
Progress in basic and clinical research of pitolisant in treating narcolepsy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(8): 1127-1132.
|
| [2] |
LI Qingyun, HUANG Ke.
Etiology, diagnosis, and current treatment of excessive daytime sleepiness
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(12): 1587-1595.
|
| [3] |
WANG Zan, WANG Ruiqi, ZHANG Yanan, CAI Lijia, SUN Qingqing.
Frontier explorations: New progress in wakefulness regulation mechanisms and its implications for new drug development
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(12): 1596-1605.
|
| [4] |
WU Huijuan, ZHAO Zhongxin.
The development of wake-promoting agents: past, present and future
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(12): 1606-1614.
|
| [5] |
ZHAN Shuqin, ZHANG Huimin, ZHANG Yimeng .
Research advances in wake-promoting drugs for the treatment of narcolepsy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(12): 1615-1624.
|
| [6] |
OU Qiong, ZHOU Ruohan, CAI Weidan.
Advances in wake-promoting agents for residual excessive daytime sleepiness in obstructive sleep apnea
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(12): 1625-1631.
|
| [7] |
ZHANG Bin, XIN Qianqian, HUANG Haokang.
Research progress on dopamine and norepinephrine reuptake inhibitors for the treatment of excessive daytime sleepiness
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(12): 1632-1639.
|
| [8] |
TANG Jiyou, HUANG Weiwei, ZHAO Mengke.
Drug research based on dual orexin receptor intervention in sleep-wake disorders: A bidirectional regulatory strategy from antagonists to agonists
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(11): 1467-1478.
|
| [9] |
KOU Liang, XIA Yun, WANG Tao.
Mechanisms and pharmacological intervention strategies of insomnia disorder
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(11): 1479-1490.
|
| [10] |
WANG Zan, WANG Ruiqi, SUN Qingqing, ZHANG Yanan.
Daridorexant: from discovery to clinical application
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(11): 1491-1499.
|
| [11] |
GUO Lijia, DONG Zixuan, WU Huizhen.
Research progress of lemborexant in the treatment of insomnia disorder
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(10): 1429-1435.
|
| [12] |
SUN Jingzi, LIU Weiying, HU Aoyan, BAO Bahu, YE Yucai, CHEN Guorong.
Research progress on the effect of opioids on obstructive sleep apnea
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(1): 125-130.
|
| [13] |
CHEN Guihai, DENG Liying, DU Yijie, HUANG Zhili, JIANG Fan, JIN Furui, LI Yanpeng, LIU Chunfeng, PAN Jiyang, PENG Yanhui, SU Changjun, TANG Jiyou, WANG Tao, WANG Zan, WU Huijuan, XUE Rong, YANG Yuechang, YU Fengchun, YU Huan, ZHAN Shuqin, ZHANG Hongju, ZHANG Lin, ZHAO Zhengqing, ZHAO Zhongxin.
Expert consensus on the diagnosis and treatment of insomnia in specified populations
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(8): 841-852.
|
| [14] |
CHEN Sirui, LI Junqiang, DANG Xiaoli, WANG Tiancheng.
Progress in researches for perampanel in the treatment of comorbidities of epilepsy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(3): 354-360.
|
| [15] |
WU Xingdong, YUE Hongmei, ZHU Haobin, LIU Miaomiao, LI Yating, XU Jinhui.
Research progress of pharmacologic therapy in obstructive sleep apnea
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(2): 215-229.
|